By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
Federal health officials are investigating a multi-state outbreak of two strains of salmonella connected to two recalled supplementary powders.
A massive multi-category product recall has been issued after a pest infestation discovery.
Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...
The target action date for orforglipron is now April 10.
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
The FDA gave the recall the lowest risk level, Class III.
A year prior, the Biden administration gave different reasons for the start of the overdose deaths decline, describing its work to distribute more of the opioid-overdose reversing drug naloxone, ...
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.